Article Versions Notes

Zhang J, Sun S, Liu J, Zhang L, Guo D, Zhang N, Zhao J, Kong D, Xu T, Wang X, et al. Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules. 2023; 28(17):6343. https://doi.org/10.3390/molecules28176343

Zhang, Jian, Simin Sun, Jinyu Liu, Liang Zhang, Di Guo, Naixin Zhang, Jun Zhao, Dexin Kong, Tongqiang Xu, Xuejian Wang, and et al. 2023. "Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer" Molecules 28, no. 17: 6343. https://doi.org/10.3390/molecules28176343

Zhang, J., Sun, S., Liu, J., Zhang, L., Guo, D., Zhang, N., Zhao, J., Kong, D., Xu, T., Wang, X., Xu, W., Li, X., & Jiang, Y. (2023). Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules, 28(17), 6343. https://doi.org/10.3390/molecules28176343